Skip to main content

Table 1 Patient characteristics and outcome

From: Patient and/or family controlled palliative sedation with midazolam for intractable symptom control: a case series

Case

Age/Sex

TUMOR (METASTASIS)

MAIN Symptoms

PPI

Family satisfaction

MEAN midazolam dose/day

analgesic dose/Day at the time sedation started

1

38, M

Gastric (lung, bowel)

pain, dyspnea, agitation

9

good

17 mg

TTS Fentanyl 100 mcg/h + Morphine 80 mg/day IV

2

24, M

Kidney (lung, omentum)

pain, dyspnea, agitation

10

good

34 mg

TTS Fentanyl 75 mcg/h + Morphine 100 mg/day IV

3

64, F

Colon (bone, bowel, pelvis, rectum)

pain, agitation

9

good

12 mg

TTS Fentanyl 75 mcg/h + Morphine 40 mg/day IV

4

55, M

Pancreas (liver, bowel)

pain, dyspnea, agitation

9

fair

20 mg

TTS Fentanyl 150 mcg/h + Morphine 60 mg/day IV

5

73, F

Pancreas (bowel, liver)

pain, agitation

10

good

15 mg

TTS Fentanyl 50 mcg/h + Morphine 30 mg/day IV

6

40, M

Gastric (liver, lung)

Pain, agitation

8

good

40 mg

TTS Fentanyl 150 mcg/h + Morphine 40 mg/day IV

7

64, F

Liver (Lung)

Pain, agitation

8

good

25 mg

TTS Fentanyl 150 mcg/h + Epidural analgesia (Levobupivacaine 2,2 mg/ml, Fentanyl 10 mcg/ml, 5–10 ml/h)

8

67, M

Liver (bowel, lung)

Pain, agitation

9

good

19 mg

TTS Fentanyl 100 mcg/h + Epidural analgesia (Levobupivacaine 2 mg/ml, Fentanyl 5 mcg/ml, 5–9 ml/h)